Therapeutic Delivery – News and Features

Researchers have developed a new nanomaterial that is capable of simultaneously performing functions to aid in cancer diagnosis, treatment and immune response induction.

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant, according to a study.

Dr. Tomek Czernuszewicz shares insights on the limitations of traditional delivery techniques and how Revvity is advancing in vivo imaging through AI-powered tools.

The article explores the importance of host cell protein analysis in biologics manufacturing, detailing challenges in detection, evolving analytical methods and increasing regulatory expectations.

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.

To reveal the science behind the protein–nanoparticle interaction and its implications for human health, a team of researchers conducted a series of spectroscopy-based experiments.

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine could revolutionize how hospitals treat rare diseases, even in low-resource settings.

Since 2010, progress in vaccine coverage has stalled or reversed in many countries, with measles vaccination declining in 100 of 204 countries between 2010 and 2019.

Scientists have developed a new type of nanoparticle made from a medical polymer and blood protein that can carry larger amounts of disease-fighting drugs and remain stable for longer than current alternative nanoparticle systems.

Solvent polarity plays a critical role in determining how effectively drugs can be loaded into metal-organic framework (MOF) carriers, a new study has found. This previously overlooked factor could help to improve drug delivery.